Literature DB >> 15951997

Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme--a quantitative radiological analysis.

Jens P Schneider1, Christos Trantakis, Matthias Rubach, Thomas Schulz, Juergen Dietrich, Dirk Winkler, Christof Renner, Ralf Schober, Kathrin Geiger, Oana Brosteanu, Claus Zimmer, Thomas Kahn.   

Abstract

Patients with supratentorial high-grade glioma underwent surgery within a vertically open 0.5-T magnetic resonance (MR) system to evaluate the efficacy of intraoperative MR guidance in achieving gross-total resection. For 31 patients, preoperative clinical data and MR findings were consistent with the putative diagnosis of a high-grade glioma, in 23 cases in eloquent regions. Tumor resections were carried out within a 0.5-T MR SIGNA SP/i (GE Medical Systems, USA). The resection of the lesion was carried out using fully MR compatible neurosurgical equipment and was stopped at the point when the operation was considered complete by the surgeon viewing the operation field with the microscope. We repeated imaging to determine the residual tumor volume only visible with MRI. Areas of tissue that were abnormal on these images were localized in the bed of resection by using interactive MR guidance. The procedure of resection, imaging control and interactive image guidance was repeated where necessary. Almost all tissue with abnormal characteristics was resected, with the exception of tissue localized in eloquent brain areas. The diagnosis of glioblastoma was confirmed in all 31 cases. When comparing the tumor volume before resection and at the point where the neurosurgeon would otherwise have terminated surgery ("first control"), residual tumor tissue was detectable in 29/31 patients; the mean residual tumor volume was 30.7 +/- 24%. After repeated resections under interactive image guidance the mean residual tumor volume was 15.1%. At this step we found tumor remnants only in 20/31 patients. The perioperative morbidity (12.9%) was low. Twenty-seven patients underwent sufficient postoperative radiotherapy. We found a significant difference (log(rank)p = 0.0037) in the mean survival times of the two groups with complete resection (n = 10, median survival time 537 days) and incomplete resection (n = 17, median survival time 237 days). The resection of primary glioblastoma multiforme under intraoperative MR guidance as demonstrated is a possibility to achieve a more complete removal of the tumor than with conventional techniques. In our small but homogeneous patient group we found an increase in the median survival time in patients with MRI for complete tumor resection, and the overall surgical morbidity was low.

Entities:  

Mesh:

Year:  2005        PMID: 15951997     DOI: 10.1007/s00234-005-1397-1

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  61 in total

1.  A mobile high-field magnetic resonance system for neurosurgery.

Authors:  G R Sutherland; T Kaibara; D Louw; D I Hoult; B Tomanek; J Saunders
Journal:  J Neurosurg       Date:  1999-11       Impact factor: 5.115

2.  Treatment by a specialist surgical neuro-oncologist does not provide any survival advantage for patients with a malignant glioma.

Authors:  A Z Latif; D F Signorini; I R Whittle
Journal:  Br J Neurosurg       Date:  1998-02       Impact factor: 1.596

3.  Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

Authors:  M Ammirati; N Vick; Y L Liao; I Ciric; M Mikhael
Journal:  Neurosurgery       Date:  1987-08       Impact factor: 4.654

4.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  W Stummer; S Stocker; S Wagner; H Stepp; C Fritsch; C Goetz; A E Goetz; R Kiefmann; H J Reulen
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

5.  Postoperative contrast enhancement in patients with brain tumor.

Authors:  J G Cairncross; J H Pexman; M P Rathbone; R F DelMaestro
Journal:  Ann Neurol       Date:  1985-06       Impact factor: 10.422

Review 6.  Intraoperative MR systems. Midfield approaches.

Authors:  R B Schwartz; D F Kacher; R S Pergolizzi; F A Jolesz
Journal:  Neuroimaging Clin N Am       Date:  2001-11       Impact factor: 2.264

7.  A population-based study of glioblastoma multiforme.

Authors:  L Paszat; N Laperriere; P Groome; K Schulze; W Mackillop; E Holowaty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-09-01       Impact factor: 7.038

8.  Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors.

Authors:  P J Miller; R S Hassanein; P G Giri; B F Kimler; P O'Boynick; R G Evans
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-08       Impact factor: 7.038

9.  Clinical results in MR-guided therapy for malignant gliomas.

Authors:  C Trantakis; D Winkler; D Lindner; G Strauss; C Nagel; J P Schneider; J Meixensberger
Journal:  Acta Neurochir Suppl       Date:  2003

10.  Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

Authors:  B C Devaux; J R O'Fallon; P J Kelly
Journal:  J Neurosurg       Date:  1993-05       Impact factor: 5.115

View more
  31 in total

1.  Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Giuseppe M Giannatempo; Teresa Popolizio; Domenico Catapano; Simona Bonavita; Nicola Maggialetti; Michela Tosetti; Ugo Salvolini; Vincenzo A d'Angelo; Giocchino Tedeschi
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

2.  Non-rigid alignment of pre-operative MRI, fMRI, and DT-MRI with intra-operative MRI for enhanced visualization and navigation in image-guided neurosurgery.

Authors:  Neculai Archip; Olivier Clatz; Stephen Whalen; Dan Kacher; Andriy Fedorov; Andriy Kot; Nikos Chrisochoides; Ferenc Jolesz; Alexandra Golby; Peter M Black; Simon K Warfield
Journal:  Neuroimage       Date:  2006-12-23       Impact factor: 6.556

3.  Intraoperative Magnetic Resonance Imaging in Intracranial Glioma Resection: A Single-Center, Retrospective Blinded Volumetric Study.

Authors:  Olutayo Ibukunolu Olubiyi; Aysegul Ozdemir; Fatih Incekara; Yanmei Tie; Parviz Dolati; Liangge Hsu; Sandro Santagata; Zhenrui Chen; Laura Rigolo; Alexandra J Golby
Journal:  World Neurosurg       Date:  2015-05-01       Impact factor: 2.104

4.  3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.

Authors:  Manickam Muruganandham; Patrick P Clerkin; Brian J Smith; Carryn M Anderson; Ann Morris; Aristides A Capizzano; Vincent Magnotta; Sarah M McGuire; Mark C Smith; John E Bayouth; John M Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-06-28       Impact factor: 7.038

Review 5.  Neurosurgical oncology: advances in operative technologies and adjuncts.

Authors:  Randy S D'Amico; Benjamin C Kennedy; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2014-06-27       Impact factor: 4.130

6.  Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.

Authors:  Lova Sun; Daniel Y Joh; Ajlan Al-Zaki; Melissa Stangl; Surya Murty; James J Davis; Brian C Baumann; Michelle Alonso-Basanta; Gary D Kaol; Andrew Tsourkas; Jay F Dorsey
Journal:  J Biomed Nanotechnol       Date:  2016-02       Impact factor: 4.099

7.  Frequency and Evolution of New Postoperative Enhancement on 3 Tesla Intraoperative and Early Postoperative Magnetic Resonance Imaging.

Authors:  Nityanand Miskin; Prashin Unadkat; Michael E Carlton; Alexandra J Golby; Geoffrey S Young; Raymond Y Huang
Journal:  Neurosurgery       Date:  2020-08-01       Impact factor: 4.654

8.  Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.

Authors:  Daniela Kuhnt; Andreas Becker; Oliver Ganslandt; Miriam Bauer; Michael Buchfelder; Christopher Nimsky
Journal:  Neuro Oncol       Date:  2011-09-12       Impact factor: 12.300

9.  Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

Authors:  Kaisorn L Chaichana; Ignacio Jusue-Torres; Rodrigo Navarro-Ramirez; Shaan M Raza; Maria Pascual-Gallego; Aly Ibrahim; Marta Hernandez-Hermann; Luis Gomez; Xiaobu Ye; Jon D Weingart; Alessandro Olivi; Jaishri Blakeley; Gary L Gallia; Michael Lim; Henry Brem; Alfredo Quinones-Hinojosa
Journal:  Neuro Oncol       Date:  2013-11-26       Impact factor: 12.300

Review 10.  Surgical resection of malignant gliomas-role in optimizing patient outcome.

Authors:  Ilker Y Eyüpoglu; Michael Buchfelder; Nic E Savaskan
Journal:  Nat Rev Neurol       Date:  2013-01-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.